M. Jabeur, H. Slim, R. Gargouri, A. Bahloul, S. Charfeddine, T. Ellouze, F. Triki, L. Abid
{"title":"Prognostic value of lung ultrasound in acute heart failure","authors":"M. Jabeur, H. Slim, R. Gargouri, A. Bahloul, S. Charfeddine, T. Ellouze, F. Triki, L. Abid","doi":"10.1016/j.acvd.2024.10.045","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>Clinical congestion rather than low cardiac output, is the most frequent cause in patients hospitalized for heart failure and accounts for high rates of death. Persisting symptoms and signs of congestion at discharge or amongst out-patients are strong predictors of an adverse outcome. Lung ultrasound (LUS) has emerged as a simple, non-invasive and semi-quantitative tool for the detection and the assessment of pulmonary congestion.</div></div><div><h3>Objective</h3><div>Assess the prognostic importance of pulmonary congestion detected with LUS on short-term adverse events and to describe the dynamic changes of LUS findings.</div></div><div><h3>Method</h3><div>In a bi-centric prospective observational study, we included consecutive patients hospitalized for acute heart failure. Each patient underwent a thorough clinical examination, a biological evaluation, a chest X-ray, LUS and echocardiography. The operators performing LUS were blinded to clinical data and examined 8 thoracic zones .The main clinical outcomes were a composite of urgent visit, HF hospitalization for acute decompensation of HF or cardiac death.</div></div><div><h3>Results</h3><div>A total of 116 individuals were included (median, 69 years of age; 53% men; mean ejection fraction 40%) The mean number of B-lines at discharge was 6.6<!--> <!-->±<!--> <!-->3.3. During a mean follow-up of 6 months, we detected 72 events: 52 patients were admitted due to severe HF symptoms and 20 patients died from cardiac cause. By multivariate analysis,<!--> <!-->≥<!--> <!-->3 B-lines Bilaterally (11.024 HR, 95% CI 5.542–21.926, <em>P</em> <!--><<!--> <!-->0.001) was retained as a predictor for the risk of the combined endpoint at 180-day follow-up. The number of B-lines significantly decreased from 31.9<!--> <!-->±<!--> <!-->12.7 when patients were admitted at the hospital to 6.6<!--> <!-->±<!--> <!-->3.1 when discharged from it (<em>P</em> <!-->=<!--> <!-->0).</div></div><div><h3>Conclusion</h3><div>A simplified 8-Zone LUS method is useful to assess severity and monitor the resolution of lung congestion. Patients with persistent pulmonary congestion at discharge assessed by LUS have worse prognosis.</div></div>","PeriodicalId":55472,"journal":{"name":"Archives of Cardiovascular Diseases","volume":"118 1","pages":"Page S45"},"PeriodicalIF":2.2000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Archives of Cardiovascular Diseases","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1875213624003905","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/15 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction
Clinical congestion rather than low cardiac output, is the most frequent cause in patients hospitalized for heart failure and accounts for high rates of death. Persisting symptoms and signs of congestion at discharge or amongst out-patients are strong predictors of an adverse outcome. Lung ultrasound (LUS) has emerged as a simple, non-invasive and semi-quantitative tool for the detection and the assessment of pulmonary congestion.
Objective
Assess the prognostic importance of pulmonary congestion detected with LUS on short-term adverse events and to describe the dynamic changes of LUS findings.
Method
In a bi-centric prospective observational study, we included consecutive patients hospitalized for acute heart failure. Each patient underwent a thorough clinical examination, a biological evaluation, a chest X-ray, LUS and echocardiography. The operators performing LUS were blinded to clinical data and examined 8 thoracic zones .The main clinical outcomes were a composite of urgent visit, HF hospitalization for acute decompensation of HF or cardiac death.
Results
A total of 116 individuals were included (median, 69 years of age; 53% men; mean ejection fraction 40%) The mean number of B-lines at discharge was 6.6 ± 3.3. During a mean follow-up of 6 months, we detected 72 events: 52 patients were admitted due to severe HF symptoms and 20 patients died from cardiac cause. By multivariate analysis, ≥ 3 B-lines Bilaterally (11.024 HR, 95% CI 5.542–21.926, P < 0.001) was retained as a predictor for the risk of the combined endpoint at 180-day follow-up. The number of B-lines significantly decreased from 31.9 ± 12.7 when patients were admitted at the hospital to 6.6 ± 3.1 when discharged from it (P = 0).
Conclusion
A simplified 8-Zone LUS method is useful to assess severity and monitor the resolution of lung congestion. Patients with persistent pulmonary congestion at discharge assessed by LUS have worse prognosis.
临床充血而不是低心排血量,是心力衰竭住院患者最常见的原因,也是死亡率高的原因。出院时或门诊患者中持续的充血症状和体征是不良结果的有力预测因素。肺超声(LUS)已成为一种简单、无创、半定量的检测和评估肺充血的工具。目的评价LUS检测肺充血对短期不良事件的预后重要性,并描述LUS结果的动态变化。方法在一项双中心前瞻性观察研究中,我们纳入了因急性心力衰竭住院的连续患者。每位患者均接受了全面的临床检查、生物学评估、胸部x光、LUS和超声心动图检查。实施LUS的操作者对临床资料不知情,并检查了8个胸椎区域。主要临床结果是急诊就诊、心衰急性失代偿住院或心源性死亡的综合结果。结果共纳入116例患者(中位数69岁;男性53%;平均射血分数40%)放电时平均b线数为6.6±3.3条。在平均6个月的随访中,我们发现72例事件:52例患者因严重HF症状入院,20例患者死于心脏原因。通过多变量分析,≥3条双侧b线(11.024 HR, 95% CI 5.542-21.926, P <;0.001)作为180天随访时联合终点风险的预测因子。b线数由入院时的31.9±12.7条减少至出院时的6.6±3.1条,差异有统计学意义(P = 0)。结论简化的8区LUS法可用于评估肺充血的严重程度和监测其消退情况。LUS评估的出院时持续性肺充血患者预后较差。
期刊介绍:
The Journal publishes original peer-reviewed clinical and research articles, epidemiological studies, new methodological clinical approaches, review articles and editorials. Topics covered include coronary artery and valve diseases, interventional and pediatric cardiology, cardiovascular surgery, cardiomyopathy and heart failure, arrhythmias and stimulation, cardiovascular imaging, vascular medicine and hypertension, epidemiology and risk factors, and large multicenter studies. Archives of Cardiovascular Diseases also publishes abstracts of papers presented at the annual sessions of the Journées Européennes de la Société Française de Cardiologie and the guidelines edited by the French Society of Cardiology.